Associations of phthalate and phthalate alternative metabolites in urine with the risk of gallstones in adults: a cross-sectional analysis
- PMID: 39760927
- DOI: 10.1007/s10653-024-02354-z
Associations of phthalate and phthalate alternative metabolites in urine with the risk of gallstones in adults: a cross-sectional analysis
Abstract
It remains unclear whether phthalates are associated with gallstones and whether the associations of phthalate alternatives with gallstones are different from traditional phthalates. In this study, 1735 participants from the NHANES 2017-2018 were included and their urine was used to detect phthalate metabolites. We used logistic and restricted cubic spline regressions to assess individual associations and dose-response relationships between phthalate metabolites and gallstones, quantile g-computation and Bayesian kernel machine regression to assess mixed associations of phthalate metabolites with gallstones, and subgroup analyses to explore potential effect modifiers. We observed that individual associations of cyclohexane-1,2-dicarboxylic acid-mono(carboxyoctyl) ester phthalate (MCOCHP) (OR: 1.423, 95% CI: 1.098-1.844) and cyclohexane 1,2-dicarboxylic acid monohydroxy isononyl ester (MHNCH) (OR: 1.380, 95% CI: 1.080-1.763) with gallstones were linearly positive, mixed association of phthalate metabolites (OR: 2.453, 95% CI: 1.054-5.708) with gallstones was also positive, and MCOCHP and MHNCH had positive weights. The associations of phthalate metabolites with gallstones were higher in the males and participants with age ≥ 60 years, BMI ≥ 30 kg/m2, hypertension, and diabetes. MCOCHP and MHNCH had the highest groupPIP (groupPIP: 0.941), mono(2-ethyl-5-carboxypentyl) terephthalate (MECPTP) had the highest condPIP (condPIP: 0.721), and mono(2-ethyl-5-carboxypentyl) phthalate (MECPP), MCOCHP, and mono-isobutyl phthalate (MiBP) also had high condPIPs (condPIP > 0.5). The trend in mixed associations of phthalate metabolites with gallstones was positive. Our study suggests that traditional phthalates and phthalate alternatives are associated with gallstones, especially in the elderly, men, obese, hypertensive populations, and diabetic populations, and phthalate alternatives are associated with a higher risk of gallstones.
Keywords: Adults; Combined exposure; Gallstone disease; Phthalates.
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no competing interests. Ethical approval: All NHANES protocols have been approved by the National Center for Health Statistics (NCHS) Ethics Review Board and all participants are informed consent.
Similar articles
-
Urinary phthalate metabolites associated with increased prevalence of gallstone disease in U.S. adults: data from the NHANES study.BMC Public Health. 2025 Jan 20;25(1):231. doi: 10.1186/s12889-025-21417-z. BMC Public Health. 2025. PMID: 39833743 Free PMC article.
-
Relationship between phthalates exposures and hyperuricemia in U.S. general population, a multi-cycle study of NHANES 2007-2016.Sci Total Environ. 2023 Feb 10;859(Pt 1):160208. doi: 10.1016/j.scitotenv.2022.160208. Epub 2022 Nov 15. Sci Total Environ. 2023. PMID: 36400295
-
Phthalate metabolite concentrations and effects on albuminuria in the US population.Ecotoxicol Environ Saf. 2023 Jan 1;249:114453. doi: 10.1016/j.ecoenv.2022.114453. Epub 2022 Dec 22. Ecotoxicol Environ Saf. 2023. PMID: 38321672
-
Individual and joint associations of per- and polyfluoroalkyl substances (PFAS) with gallstone disease in adults: A cross-sectional study.Chemosphere. 2024 Jun;358:142168. doi: 10.1016/j.chemosphere.2024.142168. Epub 2024 Apr 27. Chemosphere. 2024. PMID: 38685323
-
Association between urinary phthalate metabolites and chronic obstructive pulmonary disease incidence in US adults: results from NHANES 2007-2018.Environ Sci Pollut Res Int. 2023 Nov;30(52):113026-113038. doi: 10.1007/s11356-023-30334-w. Epub 2023 Oct 17. Environ Sci Pollut Res Int. 2023. PMID: 37848781
References
-
- Attili, A. F., Capocaccia, R., Carulli, N., Festi, D., Roda, E., Barbara, L., & Scafato, E. (1997). Factors associated with gallstone disease in the MICOL experience. Hepatology, 26(4), 809–818. https://doi.org/10.1002/hep.510260401 - DOI
-
- Banim, P. J. R., Luben, R. N., Wareham, N. J., Sharp, S. J., Khaw, K. T., & Hart, A. R. (2010). Physical activity reduces the risk of symptomatic gallstones: A prospective cohort study. European Journal of Gastroenterology & Hepatology, 22(8), 983–988. - DOI
-
- Basso, C. G., de Araújo-Ramos, A. T., & Martino-Andrade, A. J. (2022). Exposure to phthalates and female reproductive health: A literature review. Reproductive Toxicology, 109, 61–79. https://doi.org/10.1016/j.reprotox.2022.02.006 - DOI
-
- Bhat, V. S., Durham, J. L., Ball, G. L., & English, J. C. (2014). Derivation of an oral reference dose (RfD) for the nonphthalate alternative plasticizer 1,2-cyclohexane dicarboxylic acid, Di-Isononyl ester (DINCH). Journal of Toxicology and Environmental Health, Part B, 17(2), 63–94. https://doi.org/10.1080/10937404.2013.876288 - DOI
-
- Blouin, K., Boivin, A., & Tchernof, A. (2008). Androgens and body fat distribution. The Journal of Steroid Biochemistry and Molecular Biology, 108(3), 272–280. https://doi.org/10.1016/j.jsbmb.2007.09.001 - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources